Literature DB >> 28543960

Development of bullous pemphigoid during secukinumab treatment for psoriasis.

Po-Han Ho1, Tsen-Fang Tsai1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28543960     DOI： 10.1111/1346-8138.13909

Source DB:  PubMed          Journal:  J Dermatol        ISSN： 0385-2407            Impact factor:   4.005


× No keyword cloud information.
  5 in total

Review 1.  Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review.

Authors:  Chang-Yu Hsieh; Tsen-Fang Tsai
Journal:  Am J Clin Dermatol       Date:  2022-08-14       Impact factor: 6.233

Review 2.  Guselkumab-associated bullous pemphigoid in a psoriasis patient: A case report and review of the literature.

Authors:  Martina Burlando; Niccolò Capurro; Astrid Herzum; Emanuele Cozzani; Aurora Parodi
Journal:  Dermatol Ther       Date:  2021-11-30       Impact factor: 3.858

Review 3.  Interaction of Psoriasis and Bullous Diseases.

Authors:  Teruki Dainichi; Kenji Kabashima
Journal:  Front Med (Lausanne)       Date:  2018-08-08

Review 4.  Learning From Success and Failure: Biologics for Non-approved Skin Diseases.

Authors:  Reinhart Speeckaert; Jo Lambert; Nanja van Geel
Journal:  Front Immunol       Date:  2019-08-08       Impact factor: 7.561

Review 5.  The contribution of IL-17 to the development of autoimmunity in psoriasis.

Authors:  Masutaka Furue; Takafumi Kadono
Journal:  Innate Immun       Date:  2019-05-24       Impact factor: 2.680
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.